Leiden University Scholarly Publications

Your Search

Enabled Filters

  • (-) = Breast cancer
  • (-) ≠ Exemestane
  • (-) = Smit, V.T.H.B.M.

Refine Results

Resource Type

Availability

Creation Date

Show more

Language

Search results

  • RSS Feed
(1 - 20 of 21)

Pages

Addition of zoledronic acid to neoadjuvant chemotherapy is not beneficial in patients with HER2-negative stage II/III breast cancer: 5-year survival analysis of the NEOZOTAC trial (BOOG 2010-01)
Strong CD8+lymphocyte infiltration in combination with expression of HLA class I is associated with better tumor control in breast cancer patients treated with neoadjuvant chemotherapy
Prognostic value of tumor-stroma ratio combined with the immune status of tumors in invasive breast carcinoma
Systematic review of the clinical and economic value of gene expression profiles for invasive early breast cancer available in Europe
The prognostic value of the tumour-stroma ratio in primary operable invasive cancer of the breast: a validation study
Accuracy of the online prognostication tools PREDICT and Adjuvant! for early-stage breast cancer patients younger than 50 years
Identification of cell-surface markers for detecting breast cancer cells in ovarian tissue
The clinical value of HER-2 overexpression and PIK3CA mutations in the older breast cancer population: a FOCUS study analysis
The influence of insulin-like Growth Factor-1-Receptor expression and endocrine treatment on clinical outcome of postmenopausal hormone receptor positive breast cancer patients: A Dutch TEAM substudy analysis
The clinical prognostic value of molecular intrinsic tumor subtypes in older breast cancer patients: A FOCUS study analysis
Vitamin D (25-0H D3) status and pathological response to neoadjuvant chemotherapy in stage II/III breast cancer: Data from the NEOZOTAC trial (BOOG 10-01)
Insulin-like growth factor 1 receptor expression and IGF1R 3129G > T polymorphism are associated with response to neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01)
Quality assessment of estrogen receptor and progesterone receptor testing in breast cancer using a tissue microarray-based approach
Disorganised stroma determined on pre-treatment breast cancer biopsies is associated with poor response to neoadjuvant chemotherapy: Results from the NEOZOTAC trial
The prognostic and predictive value of Tregs and tumor immune subtypes in postmenopausal, hormone receptor-positive breast cancer patients treated with adjuvant endocrine therapy: a Dutch TEAM study analysis
Thyroid function alters during neoadjuvant chemotherapy in breast cancer patients: results from the NEOZOTAC trial (BOOG 2010-01)
High nuclear expression levels of histone-modifying enzymes LSD1, HDAC2 and SIRT1 in tumor cells correlate with decreased survival and increased relapse in breast cancer patients
Comparison of frequencies and prognostic effect of molecular subtypes between young and elderly breast cancer patients
The prognostic value of apoptotic and proliferative markers in breast cancer
Tumor immune subtypes distinguish tumor subclasses with clinical implications in breast cancer patients

Pages